Closely-held PharmaJet’s needle-free injection system will be used to deliver a SARS-CoV mRNA vaccine being developed by Abnova, the world’s largest antibody vaccine manufacturer. “Our system has been found to improve...
Search results for - pharmajet
PharmaJet appoints Chris Cappello as president and CEO
Chris Cappello Closely-held PharmaJet appointed Chris Cappello as its president and CEO, replacing Ron Lowy, who was appointed as executive chairman. “In the 10 years that [Mr.Cappello] has worked for PharmaJet, he has...
PharmaJet injection devices creating needle-free world
By Len Zehr Closely-held PharmaJet’s needle-free injection devices have the potential to rapidly improve the delivery of vaccines in emerging markets as well as pharmaceuticals currently under development. “We are at...
Adamas Finance subscribes for $5-million of PharmaJet bonds
Adamas Finance Asia intends to subscribe for up to $5-million in a convertible bond offering by closely-held PharmaJet, the maker of needle-free injection devices. The PharmaJet injectors have received FDA approval, CE...
PharmaJet, Mundipharma team up to boost access to needle-free drug technology
PharmaJet and Mundipharma have inked an exclusive partnership to market and distribute PharmaJet’s Tropis and Stratis needle-free drug-delivery devices to more than 120 markets around the world. The devices are designed...